A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.
The Scientist
Most Recent
Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Viral infections of the central nervous system may trigger cytokines that induce seizures.
Researchers are using modern experimental tools to probe the mysterious molecular pathways that lead to premature labor and birth.
Genetic changes that may initiate childhood leukemia could originate while the baby is still in utero.
Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.
T-cells engineered to attack B-cells sent adults’ acute leukemia into remission.
The method to the dengue virus's maddening infectiousness.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
